Ferroptotic cells augment T-cell activation and neuroinflammation
Ageing and Neurodegenerative Diseases · 2022
DOI: 10.20517/and.2022.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ageing and Neurodegenerative Diseases, 2022. Verfasst von Ying Xue und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Gefördert von: Independent Innovation Grant from Huazhong University of Science & Technology, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Since ferroptosis, a form of cell death characterized by aberrant lipid peroxidation, was proposed 10 years ago, its interaction with the immune system has been revealed gradually. On the one hand, immune cell-secreted cytokines are able to increase or suppress ferroptosis sensitivities of other cell types, such as tumor cells and fibroblasts. On the other hand, ferroptotic cell-released factors have the capacity to modulate the functions of neighboring immune cells, including dendritic cells, macrophages, and T cells. Identifying these immunomodulatory molecules generated during ferroptosis paves the way for developing novel immunotherapy strategies for treating cancer and autoimmune diseases.
Förderung
- Independent Innovation Grant from Huazhong University of Science & Technology
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Xue, Y., Lu, F., & Wang, W. (2022). Ferroptotic cells augment T-cell activation and neuroinflammation. Ageing and Neurodegenerative Diseases. https://doi.org/10.20517/and.2022.17
Vancouver
Xue Y, Lu F, Wang W. Ferroptotic cells augment T-cell activation and neuroinflammation. Ageing and Neurodegenerative Diseases. 2022. doi:10.20517/and.2022.17
BibTeX
@article{Xue2022,
author = {Xue, Ying and Lu, Fujia and Wang, Weimin},
title = {Ferroptotic cells augment T-cell activation and neuroinflammation},
journal = {Ageing and Neurodegenerative Diseases},
year = {2022},
doi = {10.20517/and.2022.17}
}
EUVIMED